Neurocrine Biosciences reported $6.2M in Interest Expense on Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
ALKERMES ALKS:US 2.41M 537K
Alnylam Pharmaceuticals ALNY:US $ 33.42M 901K
Amgen AMGN:US $ 281M 4M
Biogen BIIB:US $ 56.4M 8.3M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Cytokinetics CYTK:US $ 4.07M 0.08M
Dynavax Technologies DVAX:US $ 3.11M 1.6M
Gilead Sciences GILD:US $ 256M 1M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Halozyme Therapeutics HALO:US $ 1.75M 0.21M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
IONIS PHARMACEUT IONS:US $ 2.36M 0.06M
Nektar Therapeutics NKTR:US $ 13.09M 0.21M
Neurocrine Biosciences NBIX:US $ 6.2M 0.2M
Pfizer PFE:US $ 316M 20M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Repligen RGEN:US $ 3.14M 0.04M
Rigel Pharmaceuticals RIGL:US $ 1.76M 1.27M
Sarepta Therapeutics SRPT:US $ 15.83M 0.18M
Teva Pharmaceutical TEVA:IT 240M 1000K
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M
Xoma XOMA:US $ 172K 117K
YTE INCY:US $ 0.36M 0M
Zogenix ZGNX:US $ 3.79M 0.05M